TL;DR
Researchers have significantly boosted the brightness of bacterial bioluminescence by fusing a yellow fluorescent protein (Venus) to the bacterial luciferase. This engineered system, leveraging bioluminescence resonance energy transfer (BRET), achieves a tenfold increase in light output, enabling more sensitive and dynamic imaging in live cells, plants, and potentially animals.
What Problem Does This Paper Address?
Bacterial bioluminescence, using the lux operon, is a powerful tool for live-cell imaging because it doesn't require external excitation light, thus avoiding phototoxicity and photobleaching. However, its practical application has been hampered by relatively low brightness, requiring long exposure times that limit the observation of rapid biological processes. This paper aims to overcome this limitation by enhancing the intrinsic light output of the bacterial luciferase system.
Methods
The core of this work involves engineering the bacterial luciferase (LuxAB) by fusing it with a bright yellow fluorescent protein, Venus. The key strategy is to induce Bioluminescence Resonance Energy Transfer (BRET). This phenomenon occurs when the energy from the light emitted by the luciferase (donor) is transferred to the fluorescent protein (acceptor), which then emits its own light.
The researchers explored several fusion strategies, including different linker lengths and orientations, and importantly, the use of circularly permuted Venus (cpVenus) variants. Circular permutation can optimize the spatial arrangement and dipole orientation between the donor and acceptor, potentially enhancing BRET efficiency. They tested these constructs in Escherichia coli for basic characterization and then in human embryonic kidney cells (HEK293T) and Nicotiana benthamiana (tobacco) leaves to demonstrate their utility in more complex biological systems. For autonomous luminescence in mammalian and plant cells, they also co-expressed the substrate biosynthesis genes (luxCDE).
Datasets
Not discussed in the paper. The study primarily relies on experimental data generated from engineered cell lines and plant tissues.
Key Insights and Ideas
- BRET is a powerful enhancer: The fusion of Venus to bacterial luciferase, enabling BRET, is the primary driver of the observed brightness increase, rather than simply increased protein expression.
- Circular permutation matters: Using circularly permuted Venus variants, particularly cp157Venus, significantly improved BRET efficiency and overall luminescence compared to standard Venus fusions. This highlights the importance of precise spatial and orientational alignment between the donor and acceptor for optimal energy transfer.
- Optimized fusion site is crucial: Fusing cp157Venus to the C-terminus of LuxB (the beta subunit of luciferase) proved to be the most effective strategy for maximizing brightness.
- Color shift as a BRET indicator: The BRET process resulted in a visible shift in the emitted light from blue-green (luciferase) to green (Venus), providing a visual confirmation of successful energy transfer.
- Autonomous luminescence in complex systems: The engineered system, when combined with substrate biosynthesis genes, successfully demonstrated autonomous bioluminescence in both mammalian cells and plant leaves, paving the way for in vivo imaging applications.
Key Results
- Tenfold brightness enhancement: The optimized construct (LuxB fused to cp157Venus) achieved a tenfold increase in bioluminescence intensity in E. coli compared to the native LuxAB.
- Visible color change: The emission spectrum shifted from the typical ~490 nm of bacterial luciferase to ~528 nm, characteristic of Venus fluorescence.
- Successful demonstration in mammalian cells: HEK293T cells expressing the engineered luciferase showed a 3.5-fold increase in luminescence compared to a non-fused control, even without exogenous substrate.
- Successful demonstration in plants: Nicotiana benthamiana leaves exhibited autonomous bioluminescence, with the engineered system showing a sevenfold increase in intensity compared to the non-fused luciferase.
Limitations and Future Work
- Mechanism of enhancement: While BRET is identified as the main contributor, the exact reasons for the observed tenfold enhancement (exceeding theoretical BRET expectations) are not fully understood. The authors suggest that the fusion might alter the functional properties of the luciferase itself. Further structural and biophysical studies are needed.
- Substrate requirement: While autonomous luminescence was achieved in mammalian and plant cells by co-expressing luxCDE, the initial E. coli experiments still required the addition of decanal as a substrate. Future work could focus on fully autonomous systems in all tested organisms.
- Further optimization: The authors suggest exploring other fluorescent proteins with longer emission wavelengths (orange/red) for deeper tissue imaging, as well as further optimizing BRET pairs and linkers.
- In vivo animal studies: While the system shows promise for mammalian cells, its application for in vivo imaging in whole animals would require further validation and optimization.
Summary updated